Hepatitis B vaccination among 1997-2011 birth cohorts in rural China: the potential for further catch-up vaccination and factors associated with infant coverage rates

References

• Liu J, Fan D. Hepatitis B in China. Lancet. 2007;369(9573):1582–1583. doi:10.1016/S0140-6736(07)60723-5.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;84(40):405–419.
   PubMedGoogle Scholar
• Cui F, Wang XJ, Cao L, Liang XF, Lu Y, Hu YS, Hadler SC, Shapiro CN, Wiersma ST, Ward JW. Progress in hepatitis B prevention through universal infant vaccination China, 1997–2006. MMWR Morb Mortal Wkly Rep. 2007;56(18):441–445.
   PubMedGoogle Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China - Declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–6557. doi:10.1016/j.vaccine.2009.08.048.
   PubMed Web of Science ®Google Scholar
• Cui F, Gofin R. Immunization coverage and its determinants in children aged 12-23 months in Gansu, China. Vaccine. 2007;25(4):664–671. doi:10.1016/j.vaccine.2006.08.027.
   PubMed Web of Science ®Google Scholar
• World Health Organization. National immunization data – EPI summaries by country: data for 2015, China. World Health Organization, Western Pacific Region; 2018 [ accessed 2018 Jul 3]. http://www.wpro.who.int/immunization/documents/national_immunization_data/en/.
   Google Scholar
• Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, Trivello R. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine. 2004;22(5–6):607–610. doi:10.1016/j.vaccine.2003.09.001.
   PubMed Web of Science ®Google Scholar
• Wu G, Zhuang G-H, Wang X-L, Wang L-R, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine. 2011;29(12):2302–2307. doi:10.1016/j.vaccine.2011.01.025.
   PubMed Web of Science ®Google Scholar
• Wang F, Ma J, Hao Z, Zhang Z, Zhang X, Gao Z, Bi S, Shen L, Qiu F, Zhao Y. The long-term efficacy of Chinese hamster ovary cell derived hepatitis B vaccine after being used for 14-16 years in Chinese rural communities. Vaccine. 2015;33(2):294–297. doi:10.1016/j.vaccine.2014.11.029.
   PubMed Web of Science ®Google Scholar
• Cui F Scaling up hepatitis B vaccination with the support of GAVI in China: Lessons learned for introduction of new vaccines and for the future of hepatitis B control [ dissertation]. Basel (Switzerland): University of Basel, Faculty of Science; 2013. doi:10.5451/unibas-006173077.
   Google Scholar
• Chee G, Xie Z, Nakhimovsky S. Evaluation of GAVI-Government of China hepatitis B vaccination program. Geneva (Switzerland): Report prepared for the GAVI alliance; 2012.
   Google Scholar
• Feng X, Zhu J, Zhang L, Song L, Hipgrave D, Guo S, Ronsmans C, Guo Y, Yang Q. Socio-economic disparities in maternal mortality in China between 1996 and 2006. Br J Obstet Gynaecol. 2010;117(12):1527–1536. doi:10.1111/j.1471-0528.2010.02707.x.
   Google Scholar
• Yanqui G, Ronsmans C, Lin A. Time trends and regional differences in maternal mortality in China from 2000 to 2005. Bull World Health Organ. 2009;87(12):913–920. doi:10.2471/BLT.08.060426.
   PubMed Web of Science ®Google Scholar
• Yang W, Liang X, Cui F, Li L, Hadler SC, Hutin YJ, Kane M, Wang Y. Key outcomes and addressing remaining challenges—perspectives from a final evaluation of the China GAVI project. Vaccine. 2013;31(Suppl 9):J73–J78. doi:10.1016/j.vaccine.2012.09.060.
   PubMedGoogle Scholar
• Wang L, Li J, Chen H, Li F, Armstrong GL, Nelson C, Ze W, Shapiro CN. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ. 2007;85(9):649–732. doi:10.2471/BLT.06.037002.
   Web of Science ®Google Scholar
• Hutin Y, Hennessey K, Cairns L, Zhang Y, Li H, Zhao L, Cui F, Lee L, Tan V, Takashima Y, et al. Improving hepatitis B vaccine timely birth dose coverage: lessons from five demonstration projects in China, 2005–2009. Vaccine. 2013;31(Suppl9):J49–J55. doi:10.1016/j.vaccine.2013.03.025.
   PubMedGoogle Scholar
• Wang S, Smith H, Peng Z, Xu B, Wang W. Increasing coverage of hepatitis B vaccination in China: a systematic review of interventions and implementation experiences. Medicine. 2016;95(19):1–15. doi:10.1097/MD.0000000000003693.
   Web of Science ®Google Scholar
• World Health Organization. WHO Vaccine-preventable diseases: monitoring system, 2018 global summary. Geneva:World Health Organization; 2018 [ accessed 2018 Jul 3]. http://apps.who.int/immunization_monitoring/globalsummary/estimates?c=CHN.
   Google Scholar
• Liang X, Bi S, Wang Y. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009;200(1):39–47. doi:10.1086/599332.
   PubMed Web of Science ®Google Scholar
• Lin X, Yang J, Lu H, Zhou Y, Zhou G, Wu H. Minimization of hepatitis B infection among children in Jiangsu, China, 12 years after integration of hepatitis B vaccine into the expanded program on immunization. Vaccine. 2016;34(51):6458–6463. doi:10.1016/j.vaccine.2016.11.022.
   PubMed Web of Science ®Google Scholar
• Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–772. doi:10.3201/eid2305.161477.
   PubMed Web of Science ®Google Scholar
• Fang Z-L, Harrison TJ, Yang J-Y, Chen Q-Y, Wang X-Y, Mo J-J. Prevalence of Hepatitis B virus infection in a highly endemic area of Southern China after catch-up immunization. J Med Virol. 2012;84(6):878–884. doi:10.1002/jmv.23278.
   PubMed Web of Science ®Google Scholar
• Hutton DW, Brandeau ML. Too much of a good thing? When to stop catch-up vaccination. Med Decis Making. 2013;33(7):920–936. doi:10.1177/0272989X13493142.
   PubMed Web of Science ®Google Scholar
• Zou L, Zhang W, Ruan S. Modeling the transmission dynamics and control of hepatitis B virus in China. J Theor Biol. 2010;262(2):330–338. doi:10.1016/j.jtbi.2009.09.035.
   PubMed Web of Science ®Google Scholar
• Zou L, Ruan S, Zhang W. An age-structured model for the transmission dynamics of hepatitis B. Siam J Appl Math. 2010;70(8):1321–3139. doi:10.1137/090777645.
   Web of Science ®Google Scholar
• Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross-sectional study. Lancet Infect Dis. 2016;16(1):80–86. doi:10.1016/S1473-3099(15)00218-2.
   PubMed Web of Science ®Google Scholar
• Zhu D, Wang J, Wangen KR. Hepatitis B vaccination coverage rates among adults in rural China: are economic barriers relevant? Vaccine. 2014;32(49):6705–6710. doi:10.1016/j.vaccine.2013.06.095.
   PubMed Web of Science ®Google Scholar
• Luna EJ, Veras MA, Flannery B, De Moraes JC. Group tVCS. Household survey of hepatitis B vaccine coverage among Brazilian children. Vaccine. 2009;27(39):5326–5331. doi:10.1016/j.vaccine.2009.06.096.
   PubMed Web of Science ®Google Scholar
• Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, Gong X, Hutin YJ, Cairns KL, Liang X, et al. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992–2005. Vaccine. 2010;28(37):5973–5978. doi:10.1016/j.vaccine.2010.06.111.
   PubMed Web of Science ®Google Scholar
• Cui F, Luo H, Wang F, Zheng H, Gong X, Chen Y, Wu Z, Miao N, Kane M, Hennessey K, et al. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation. Vaccine. 2013;31(Suppl 9):J36–J42. doi:10.1016/j.vaccine.2012.11.061.
   PubMedGoogle Scholar
• Wu J-N, Li D-J, Zhou Y. Association between timely initiation of hepatitis B vaccine and completion of the hepatitis B vaccine and national immunization program vaccine series. Int J Infect Dis. 2016;51:.62–65. doi:10.1016/j.ijid.2016.08.018.
   PubMed Web of Science ®Google Scholar
• Hadler SC, Fuqiang C, Averhoff F, Taylor T, Fuzhen W, Li L, Xiaofeng L, Weizhong Y. The impact of hepatitis B vaccine in China and in the China GAVI project. Vaccine. 2013;31(Suppl 9):J66–J72. doi:10.1016/j.vaccine.2013.03.043.
   PubMedGoogle Scholar
• Hesketh T, Lu L, Xing ZW. The effect of China’s one-child family policy after 25 years. N Engl J Med. 2005;353(11):1171–1176. doi:10.1056/NEJMhpr051833.
   PubMed Web of Science ®Google Scholar
• Zhu WX, Lu L, Hesketh T. China’s excess males, sex selective abortion, and one child policy: analysis of data from 2005 national intercensus survey. BMJ. 2009;338(7700):920–923. doi:10.1136/bmj.b1211.
   Google Scholar
• Anderson S, Ray D. Missing women: age and disease. Rev Econ Stud. 2010;77(44):1262–1300. doi:10.1111/j.1467-937X.2010.00609.x.
   Google Scholar
• Bulte E, Heerink N, Zhang X. China’s one-child policy and ‘the mystery of missing women’: ethnic minorities and male-biased sex ratios. Oxf Bull Econ Stat. 2011;73(1):21–39. doi:10.1111/j.1468-0084.2010.00601.x.
   Web of Science ®Google Scholar
• Goodkind D. Child underreporting, fertility, and sex ratio imbalance in China. Demography. 2011;48(1):291–316. doi:10.1007/s13524-010-0007-y.
   PubMed Web of Science ®Google Scholar
• Hennessey K, Mendoza-Aldana J, Bayutas B, Lorenzo-Mariano KM, Diorditsa S. Hepatitis B control in the World Health Organization’s Western Pacific Region: targets, strategies, status. Vaccine. 2013;31(Suppl 9):J85–J92. doi:10.1016/j.vaccine.2012.10.082.
   PubMedGoogle Scholar
• Chen J, Chang E, Chen Y-R, Bailey M, So S. A model program for hepatitis B vaccination and education of schoolchildren in rural China. Int J Public Health. 2012;57(3):581–588. doi:10.1007/s00038-011-0289-x.
   PubMed Web of Science ®Google Scholar
• Hutton DW, So SK, Brandeau ML. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology. 2010;51(2):405–414. doi:10.1002/hep.23310.
   PubMed Web of Science ®Google Scholar